Temperament Characteristics, Anxiety and Depression in People with Familial Mediterranean Fever
No Thumbnail Available
Date
2023
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Objective: Familial Mediterranean Fever (FMF) is an autosomal recessive and self-limiting disease. FMF is characterized by recurrent episodes of fever, peritonitis, synovitis and pleuritis. Individuals with chronic illness tend to experience depression or anxiety. It has also been stated that affective temperaments are the basis of mood disorders. The aim of our study is to determine the frequency of anxiety and depression in FMF patients, to determine the dominant temperament type, and to compare the findings with the healthy control group. Method: 73 patients with FMF and 30 age- and gender-matched healthy individuals without any systemic disease were included in the study. The hospital anxiety and depression scale were used to measure depression and anxiety, and the Temperament Evaluation of Memphis, Pisa, Paris and San Diego –Autoquestionnaire temperament scale was used to determine the temperament type. Results: The number of cases with high anxiety score was 33 (45.2%) in the patient group and five (16.6%) in the control group; The number of cases with high depression score was 23 (31.5%) in the patient group and two (6.6%) in the control group, and both were also found to be statistically significantly higher. (P values p=0.007 and p=0.01, respectively). Gender, age, disease duration, regular use of treatment, existence of gene mutation, attack type, and anxiety and depression scores had no statistically significant link. The percentage of patients identified with depressive temperament (20.5%) was higher than the control group (3.3%), according to the TEMPS-A temperament scale, and the difference was statistically significant (p=0.035). Conclusion: When the clinical picture in FMF patients becomes complicated with anxiety or depression or in the presence of a temperament predisposed to these conditions, there may be various problems in patients' compliance and response to treatment. FMF patients should be monitored for accompanying anxiety or depression during follow-up.